ravulizumab

Summary

ravulizumab is a monoclonal antibody^[1]. ravulizumab ranks in the top 6% of monoclonal_antibody entities by monthly Wikipedia readership (195 views/month).^[2]

Key Facts

• ravulizumab's instance of is recorded as monoclonal antibody^[3].
• ravulizumab's instance of is recorded as medication^[4].
• ravulizumab's CAS Registry Number is recorded as 1803171-55-2^[5].
• ravulizumab's Guide to Pharmacology Ligand ID is recorded as 10168^[6].
• ravulizumab's UNII is recorded as C3VX249T6L^[7].
• ravulizumab's KEGG ID is recorded as D11054^[8].
• ravulizumab's DrugBank ID is recorded as DB11580^[9].
• ravulizumab's Google Knowledge Graph ID is recorded as /g/11f4qfcb5z^[10].
• ravulizumab's RxNorm CUI is recorded as 2107301^[11].
• ravulizumab's legal status is recorded as boxed warning^[12].
• ravulizumab's LiverTox ID is recorded as Ravulizumab^[13].
• ravulizumab's LiverTox likelihood score is recorded as LiverTox toxicity likelihood category E*^[14].
• ravulizumab's MedlinePlus drug identifier is recorded as a619014^[15].
• ravulizumab's WikiProjectMed ID is recorded as Ravulizumab^[16].

Why It Matters

ravulizumab ranks in the top 6% of monoclonal_antibody entities by monthly Wikipedia readership (195 views/month).^[2] ravulizumab has Wikipedia articles in 10 language editions, a strong signal of global cultural recognition.^[17]